ANGPTL4 and focal segmental glomerulosclerosis: No statistical differences were observed in serum Angptl4 levels among patients with MCD, FSGS and MN patients during relapse compared to the same group of patients during remission and in those patients during remission compared to controls (S1A and S1B Figrespectively).